ANRO (Alto Neuroscience) Institutional Ownership: 80.35% (As of Jul. 09, 2026)


ANRO Alto Neuroscience Inc ANRO
12 GF Score
Price $26.80
! 2 Warning Signs
View Full Analysis

What is Alto Neuroscience Institutional Ownership?

Alto Neuroscience ANRO +2.72% 12 Institutional Ownership is 80.35% as of Jul. 09, 2026. GuruFocus rates ANRO with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Alto Neuroscience's institutional ownership is 80.35%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Alto Neuroscience's Insider Ownership is 2.65%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Alto Neuroscience's Float Percentage Of Total Shares Outstanding is 83.64%.

Alto Neuroscience Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Alto Neuroscience's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience Institutional Ownership Chart

Alto Neuroscience Historical Data

The historical data trend for Alto Neuroscience can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 13.29 12.27 12.21 13.46 13.59 13.60 13.40 12.86 11.43 14.72
ANRO
12GF Score
Alto Neuroscience Inc ANRO
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alto Neuroscience Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 80.35% mean?
Alto Neuroscience (ANRO) has a Institutional Ownership of 80.35% as of Jul. 09, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Alto Neuroscience and its competitors.
Is Alto Neuroscience's Institutional Ownership too high?
Alto Neuroscience's current Institutional Ownership is 80.35%. Overall, Alto Neuroscience has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Alto Neuroscience's Institutional Ownership compare to SANA and AVTX?
Alto Neuroscience's Institutional Ownership of 80.35% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Alto Neuroscience and its competitors. Alto Neuroscience's current Institutional Ownership is 80.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alto Neuroscience stock overvalued right now?
Alto Neuroscience (ANRO) has a current Institutional Ownership of 80.35%. The current Institutional Ownership is 80.35%. Alto Neuroscience's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Alto Neuroscience (ANRO), the current Institutional Ownership is 80.35% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alto Neuroscience Business Description

Address 650 Castro Street, Suite 450, Mountain View, CA, USA, 94041
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
12GF Score

Get the complete analysis for ANRO

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.80
Price